药品名: Imatinib Cipla 400 mg tvrde kapsule** 以前药品名: 营销授权编号: HR-H-732649420 活性物质: imatinibum 药品形式: kapsula, tvrda 剂量: 400 mg 包装: 10 kapsula u blisteru, u kutiji (HR-H-732649420-01)
30 kapsula u blisteru, u kutiji (HR-H-732649420-02)
90 kapsula u blisteru, u kutiji (HR-H-732649420-03) 生产商: S&D Pharma CZ, spol. s r.o, Pchery (Pharmos a.s. facility), Češka;
Cipla (EU) Limited, London, Ujedinjeno Kraljevstvo;
Cipla Europe NV, Antwerp, Belgija;
Pharmadox Healthcare Limited, Paola, Malta
营销授权持有人: Cipla Europe NV, Uitbreidingstraat 80, Antwerpen, Belgija 营销授权日期: 29.06.2015 MA有效期: 29.06.2020 MA撤销日期: 25.09.2017 分类编号: UP/I-530-09/14-01/111 注册编号: 381-12-01/14-15-06 组成: 1 tvrda kapsula sadrži 400 mg imatiniba (u obliku mesilata) 处方和分配: na recept, u ljekarni 处方类型: ograničeni recept 公开的信息: zabranjeno ATC编号: L01XE01 是否是在克罗地亚销售的药物产品: Ne SPC: http://www.halmed.hr/upl/lijekovi/SPC/SPC_UP-I-530-09-14-01-110-111-11555.pdf PIL: http://www.halmed.hr/upl/lijekovi/PIL/PIL_UP-I-530-09-14-01-111.pdf 直接医疗保健专业交流: http://www.halmed.hrhttps://mri.cts-mrp.eu/Human/Product/Details/44032 公开评估报告: http://www.halmed.hrhttps://mri.cts-mrp.eu/Human/Product/Details/44032 药品详细信息: http://www.halmed.hr/en/Lijekovi/Baza-lijekova/Imatinib-Cipla-400-mg-tvrde-kapsule/11555
30 kapsula u blisteru, u kutiji (HR-H-732649420-02)
90 kapsula u blisteru, u kutiji (HR-H-732649420-03) 生产商: S&D Pharma CZ, spol. s r.o, Pchery (Pharmos a.s. facility), Češka;
Cipla (EU) Limited, London, Ujedinjeno Kraljevstvo;
Cipla Europe NV, Antwerp, Belgija;
Pharmadox Healthcare Limited, Paola, Malta
营销授权持有人: Cipla Europe NV, Uitbreidingstraat 80, Antwerpen, Belgija 营销授权日期: 29.06.2015 MA有效期: 29.06.2020 MA撤销日期: 25.09.2017 分类编号: UP/I-530-09/14-01/111 注册编号: 381-12-01/14-15-06 组成: 1 tvrda kapsula sadrži 400 mg imatiniba (u obliku mesilata) 处方和分配: na recept, u ljekarni 处方类型: ograničeni recept 公开的信息: zabranjeno ATC编号: L01XE01 是否是在克罗地亚销售的药物产品: Ne SPC: http://www.halmed.hr/upl/lijekovi/SPC/SPC_UP-I-530-09-14-01-110-111-11555.pdf PIL: http://www.halmed.hr/upl/lijekovi/PIL/PIL_UP-I-530-09-14-01-111.pdf 直接医疗保健专业交流: http://www.halmed.hrhttps://mri.cts-mrp.eu/Human/Product/Details/44032 公开评估报告: http://www.halmed.hrhttps://mri.cts-mrp.eu/Human/Product/Details/44032 药品详细信息: http://www.halmed.hr/en/Lijekovi/Baza-lijekova/Imatinib-Cipla-400-mg-tvrde-kapsule/11555
填写下方邮箱进行订阅,即可获取详细说明书,另有机会获得全处方辅料含量及部分COA等!
更多信息
你必须登录或注册一个新账户,以便接触產品
有用的信息
- 仅对制药厂、医药研发公司、医药研究所、医院服务,不对个人开放!
必须要注册或登陆才可以发表评论
我们提供全球参比制剂,有需要可以评论留言
登录 注册